regLit

regLit is a digital platform that aggregates and curates regulatory documents, academic literature, and policy analyses related to healthcare regulation, data privacy, and pharmaceutical oversight. The project was initiated in 2018 by a consortium of universities and industry think‑tanks as a response to growing demand for centralized access to regulatory information for researchers, practitioners, and policymakers. Since its launch, regLit has expanded to include thousands of documents, including FDA guidance, European Medicines Agency (EMA) directives, and comparative studies on regulatory frameworks across jurisdictions.

The core function of regLit is to provide a searchable index of regulatory texts and accompanying scholarly commentary. Users can filter by region, regulatory body, subject area, or publication year. Advanced search options allow for cross‑referencing of legal provisions with evidence‑based literature, facilitating a more holistic understanding of regulatory impact. The platform also hosts a set of analytical tools that enable users to track changes in regulatory language over time and assess the uptake of proposed policy changes.

regLit is employed by academic institutions for curriculum development and by industry regulatory affairs teams to benchmark compliance strategies. Its open‑access policy has encouraged collaboration between legal scholars, data scientists, and public health experts. In addition, regulatory agencies have cited regLit in briefing documents to illustrate the reach of their communication efforts. The evolving dataset continues to grow as new guidelines and policy debates emerge worldwide, reinforcing regLit as a valuable reference for stakeholders navigating complex regulatory environments.